Ferritin Quantitative Test

SARS-CoV-2 Antigen Rapid Qualitative Test

The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.
Product Detail

Product Features

High sensitivity and specificity

Test results conveniently available in 20-30 minutes

Long shelf life of 24 months with room temperature storage

QR-code based patient tracking


Clinical Performance

Relative Sensitivity: 96.00% (88.75% - 99.17%)

Relative Specificity: 100.00% (98.34% - 100.00%)

Accuracy: 98.98% (97.06 – 99.79%)



Testing process for the SARS-CoV-2 Rapid Antigen Test

 

① Transfer 6 drops of extraction buffer to a tube.

② Insert the swab into an extraction buffer tube. While squeezing the buffer tube, stir the swab more than 10 seconds.

③ Remove the swab while squeezing the sides of the tube to extract the liquid from the swab.

④ Press the nozzle cap tightly onto the tube. Continue with 3a. Performing a test.

⑤ Place the test device on a flat surface and apply 2 drops of extracted sample in a 90° angle to the specimen well of the cassette

⑥ Read the test result at 20 to 30 mins.



Interpreting Test Results




Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
SARS-CoV-2 IgG/IgM Rapid Test
SARS-CoV-2 IgG/IgM Rapid Qualitative Test
The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.
Neutralizing Antibody Rapid Test
SARS-CoV-2 Neutralizing Antibody Rapid Test
Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
Chemiluminescence Immunoassay
CLi-1600
CLi-1600 semi-automated device which quantifies biomarkers for thyroid disease, inflammation, cardiac diseases, fertility, diabetes, bone metabolism, anemia, and health check by analyzing human serum, plasma and whole blood.
biotime PGII Rapid Quantitative Test
PGII Rapid Quantitative Test
Human Pepsinogens are aspartic proteases produced in the gastric mucosa and secreted into the gastric lumen that play a major role in the digestion of proteins after activation of acidic pH. It is synthesized as isoymogens and is classified into two groups (Pepsinogen I and Pepsinogen II).
Biotime cTnI rapid quantitative test
cTnI Rapid Quantitative Test
cTnI is a myocardial marker with high specificity and good sensitivity. The Biotime cTnI test kit has a wide detection range and high accuracy.
biotime AFP Rapid Quantitative Test
AFP Rapid Quantitative Test
Alpha-fetoprotein (AFP) is a protein produced primarily by the liver in a developing baby (fetus) and the portion of a developing embryo that is similar to the yolk cavity in bird eggs (yolk sac tissues). AFP levels are typically elevated when a baby is born and then decline rapidly.
PCT Rapid Quantitative Test (Chemiluminescence Immunoassay)
PCT Rapid Quantitative Test (Chemiluminescence Immunoassay)
PCT Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Procalcitonin concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of inflammation diseases.
Malaria Pf/Pv Antigen Qualitative Rapid Test
Malaria Pf/Pv Antigen Rapid Test
The Malaria P.f/P.v Antigen Rapid Test is a lateral flow immunoassay for the qualitative detection of Histidine-Rich Protein II (HRP-II) specific to Plasmodium falciparum (P.f) and Plasmodium lactate dehydrogenase (pLDH) specific to Plasmodium vivax (P.v) in human whole blood specimen. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with Malaria. For professional in vitro diagnostic use only.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact